Your browser doesn't support javascript.
loading
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua, Boon H; Link, Emma K; Kunkler, Ian H; Whelan, Timothy J; Westenberg, A Helen; Gruber, Guenther; Bryant, Guy; Ahern, Verity; Purohit, Kash; Graham, Peter H; Akra, Mohamed; McArdle, Orla; O'Brien, Peter; Harvey, Jennifer A; Kirkove, Carine; Maduro, John H; Campbell, Ian D; Delaney, Geoff P; Martin, Joseph D; Vu, T Trinh T; Muanza, Thierry M; Neal, Anthony; Olivotto, Ivo A.
Afiliación
  • Chua BH; Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, NSW, Australia. Electronic address: boon.chua@health.nsw.gov.au.
  • Link EK; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
  • Kunkler IH; Edinburgh Cancer Research Centre, Institute of Genetic and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.
  • Whelan TJ; McMaster University, Department of Oncology, Hamilton, ON, Canada; Juravinski Cancer Centre, Hamilton, ON, Canada.
  • Westenberg AH; Radiotherapiegroep Arnhem, Arnhem, Netherlands.
  • Gruber G; Institute for Radiotherapy, Klinik Hirslanden, Zurich, Switzerland.
  • Bryant G; University of Queensland, Brisbane, QLD, Australia.
  • Ahern V; University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Westmead, NSW, Australia.
  • Purohit K; University of Sheffield, Sheffield, UK; Weston Park Hospital, Broomhall, Sheffield, UK.
  • Graham PH; Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; St George Hospital, Kogarah, NSW, Australia.
  • Akra M; University of Manitoba, Winnipeg, MB, Canada; Cancer Care Manitoba, Winnipeg, MB, Canada.
  • McArdle O; Cancer Trials Ireland, Dublin, Ireland; St Luke's Radiation Oncology Network, Beaumont Hospital, Beaumont, Dublin, Ireland.
  • O'Brien P; University of Newcastle, Newcastle, NSW, Australia; GenesisCare, Gateshead, NSW, Australia.
  • Harvey JA; University of Queensland, Brisbane, QLD, Australia; Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
  • Kirkove C; Université Catholique de Louvain, Brussels, Belgium; Cliniques Universitaires St Luc, Bruxelles, Belgium.
  • Maduro JH; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • Campbell ID; University of Auckland, Auckland, New Zealand; Waikato Hospital, Hamilton, New Zealand.
  • Delaney GP; Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Liverpool Hospital, Liverpool, NSW, Australia.
  • Martin JD; National University of Ireland, Galway, Ireland; University Hospital Galway, Galway, Ireland.
  • Vu TTT; Université de Montréal, Montreal, QC, Canada; Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Muanza TM; Department of Oncology, McGill University, Montreal, QC, Canada.
  • Neal A; Royal Surrey County Hospital, Guildford, UK.
  • Olivotto IA; University of Calgary, Calgary, AB, Canada.
Lancet ; 400(10350): 431-440, 2022 08 06.
Article en En | MEDLINE | ID: mdl-35934006

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article